Home › Funds › Squadron Capital Management LLC › RARE

Squadron Capital Management LLC position in RARE

ULTRAGENYX PHARMACEUTICAL IN · Health Care

Squadron Capital Management LLC reported holding 55,000 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.72% of its reported portfolio and ranking #30 among its reported holdings. Squadron Capital Management LLC first reported this position in Q2 2026.

Latest position (Q2 2026)55.00K sh
Reported value held$1.84M
Portfolio Weight0.72%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's RARE position evolved

Squadron Capital Management LLC first disclosed a stake in RARE in Q2 2026 at 55,000 shares (US$1.8M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 55.00K $1.84M New

About RARE and 13F data

RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 27 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$260.3M), SANDS CAPITAL MANAGEMENT, LLC (US$105.5M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RARE

All RARE fund holders →

FAQ

How long has Squadron Capital Management LLC held RARE?

Squadron Capital Management LLC has disclosed RARE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Squadron Capital Management LLC's current position in RARE?

As of Q2 2026, Squadron Capital Management LLC holds 55.00K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $1.84M, representing 0.72% of its reported portfolio and ranking #30.

Has Squadron Capital Management LLC been buying or selling RARE?

In the latest 13F filing (Q2 2026), Squadron Capital Management LLC newly opened its position in RARE.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, SANDS CAPITAL MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.